Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 3Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Thyroid Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 7trametinib 5pembrolizumab 5selpercatinib 4dabrafenib 4Specimen Handling 4Nivolumab 4cabozantinib 3Iodine-131 3spartalizumab 2omipalisib 2lenvatinib 2durvalumab 2binimetinib 2Vemurafenib 2Sorafenib 2Ipilimumab 2Immunoglobulin G 2Disulfides 2CTLA-4 Antigen 2Biopsy 2ulixertinib 1trastuzumab biosimilar HLX02 1tislelizumab 1tipifarnib 1sapanisertib 1relatlimab 1regorafenib 1pertuzumab 1palbociclib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Thyroid Neoplasms × Dexmedetomidine × Clear all
NCT07434206 2026-02-25

Safety and Efficacy of Dexmedetomidine in Controlling Hemodynamics During Resection of Active Thyroid Secreting Tumors

South Egypt Cancer Institute

Phase 2/3 Active not recruiting
80 enrolled
Head & Neck

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡